Table 5.
Multivariate analysis for cGvHD
| cGvHD | ||
|---|---|---|
| HR (95% CI) | P value | |
| Initiate time of tapering of immunosuppressive agents (early vs routine) | 4.971 (1.34–18.442) | 0.017 |
| aGvHD (with vs without) | 4.015 (1.11–14.531) | 0.034 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.